We externally validated a clinically useful tool that predicts benign prostate pathology on magnetic resonance imaging/ultrasound fusion–targeted biopsy in men with a prior negative 12-core systematic biopsy and updated this predictive tool to improve its performance in patient counseling regarding the need for a repeat biopsy.
- External validation
- Magnetic resonance imaging/ultrasound fusion–targeted prostate biopsy
- Prior negative biopsy
- Prostate cancer
ASJC Scopus subject areas